Global Antibody Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Antibody Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
According to APO Research, The global Antibody market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Antibody include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody.
The Antibody market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Antibody segment by Type

IgM
IgG
IgA
Other
Antibody segment by Application

Therapeutic
Research
Diagnostic
Antibody Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Antibody Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Antibody Sales Estimates and Forecasts (2019-2030)
1.3 Antibody Market by Type
1.3.1 IgM
1.3.2 IgG
1.3.3 IgA
1.3.4 Other
1.4 Global Antibody Market Size by Type
1.4.1 Global Antibody Market Size Overview by Type (2019-2030)
1.4.2 Global Antibody Historic Market Size Review by Type (2019-2024)
1.4.3 Global Antibody Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Antibody Sales Breakdown by Type (2019-2024)
1.5.2 Europe Antibody Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Antibody Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Antibody Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Antibody Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Antibody Industry Trends
2.2 Antibody Industry Drivers
2.3 Antibody Industry Opportunities and Challenges
2.4 Antibody Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Antibody Revenue (2019-2024)
3.2 Global Top Players by Antibody Sales (2019-2024)
3.3 Global Top Players by Antibody Price (2019-2024)
3.4 Global Antibody Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Antibody Key Company Manufacturing Sites & Headquarters
3.6 Global Antibody Company, Product Type & Application
3.7 Global Antibody Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Antibody Market CR5 and HHI
3.8.2 Global Top 5 and 10 Antibody Players Market Share by Revenue in 2023
3.8.3 2023 Antibody Tier 1, Tier 2, and Tier 3
4 Antibody Regional Status and Outlook
4.1 Global Antibody Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Antibody Historic Market Size by Region
4.2.1 Global Antibody Sales in Volume by Region (2019-2024)
4.2.2 Global Antibody Sales in Value by Region (2019-2024)
4.2.3 Global Antibody Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Antibody Forecasted Market Size by Region
4.3.1 Global Antibody Sales in Volume by Region (2025-2030)
4.3.2 Global Antibody Sales in Value by Region (2025-2030)
4.3.3 Global Antibody Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Antibody by Application
5.1 Antibody Market by Application
5.1.1 Therapeutic
5.1.2 Research
5.1.3 Diagnostic
5.2 Global Antibody Market Size by Application
5.2.1 Global Antibody Market Size Overview by Application (2019-2030)
5.2.2 Global Antibody Historic Market Size Review by Application (2019-2024)
5.2.3 Global Antibody Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Antibody Sales Breakdown by Application (2019-2024)
5.3.2 Europe Antibody Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Antibody Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Antibody Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Antibody Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Roche
6.1.1 Roche Comapny Information
6.1.2 Roche Business Overview
6.1.3 Roche Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Antibody Product Portfolio
6.1.5 Roche Recent Developments
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Comapny Information
6.2.2 Johnson and Johnson Business Overview
6.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson and Johnson Antibody Product Portfolio
6.2.5 Johnson and Johnson Recent Developments
6.3 Merck
6.3.1 Merck Comapny Information
6.3.2 Merck Business Overview
6.3.3 Merck Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Antibody Product Portfolio
6.3.5 Merck Recent Developments
6.4 Novartis
6.4.1 Novartis Comapny Information
6.4.2 Novartis Business Overview
6.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Antibody Product Portfolio
6.4.5 Novartis Recent Developments
6.5 AbbVie
6.5.1 AbbVie Comapny Information
6.5.2 AbbVie Business Overview
6.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Antibody Product Portfolio
6.5.5 AbbVie Recent Developments
6.6 Amgen
6.6.1 Amgen Comapny Information
6.6.2 Amgen Business Overview
6.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amgen Antibody Product Portfolio
6.6.5 Amgen Recent Developments
6.7 Pfizer
6.7.1 Pfizer Comapny Information
6.7.2 Pfizer Business Overview
6.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Pfizer Antibody Product Portfolio
6.7.5 Pfizer Recent Developments
6.8 Bayer
6.8.1 Bayer Comapny Information
6.8.2 Bayer Business Overview
6.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Antibody Product Portfolio
6.8.5 Bayer Recent Developments
6.9 Lilly
6.9.1 Lilly Comapny Information
6.9.2 Lilly Business Overview
6.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lilly Antibody Product Portfolio
6.9.5 Lilly Recent Developments
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Comapny Information
6.10.2 Bristol-Myers Squibb Business Overview
6.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Antibody Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Comapny Information
6.11.2 GlaxoSmithKline Business Overview
6.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 GlaxoSmithKline Antibody Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments
6.12 Biogen
6.12.1 Biogen Comapny Information
6.12.2 Biogen Business Overview
6.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biogen Antibody Product Portfolio
6.12.5 Biogen Recent Developments
6.13 AstraZeneca
6.13.1 AstraZeneca Comapny Information
6.13.2 AstraZeneca Business Overview
6.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 AstraZeneca Antibody Product Portfolio
6.13.5 AstraZeneca Recent Developments
6.14 Sanofi
6.14.1 Sanofi Comapny Information
6.14.2 Sanofi Business Overview
6.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sanofi Antibody Product Portfolio
6.14.5 Sanofi Recent Developments
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Comapny Information
6.15.2 Alexion Pharmaceuticals Business Overview
6.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
6.15.5 Alexion Pharmaceuticals Recent Developments
6.16 Seattle Genetics
6.16.1 Seattle Genetics Comapny Information
6.16.2 Seattle Genetics Business Overview
6.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Seattle Genetics Antibody Product Portfolio
6.16.5 Seattle Genetics Recent Developments
7 North America by Country
7.1 North America Antibody Sales by Country
7.1.1 North America Antibody Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Antibody Sales by Country (2019-2024)
7.1.3 North America Antibody Sales Forecast by Country (2025-2030)
7.2 North America Antibody Market Size by Country
7.2.1 North America Antibody Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Antibody Market Size by Country (2019-2024)
7.2.3 North America Antibody Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Antibody Sales by Country
8.1.1 Europe Antibody Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Antibody Sales by Country (2019-2024)
8.1.3 Europe Antibody Sales Forecast by Country (2025-2030)
8.2 Europe Antibody Market Size by Country
8.2.1 Europe Antibody Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Antibody Market Size by Country (2019-2024)
8.2.3 Europe Antibody Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Antibody Sales by Country
9.1.1 Asia-Pacific Antibody Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Antibody Sales by Country (2019-2024)
9.1.3 Asia-Pacific Antibody Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Antibody Market Size by Country
9.2.1 Asia-Pacific Antibody Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Antibody Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Antibody Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Antibody Sales by Country
10.1.1 Latin America Antibody Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Antibody Sales by Country (2019-2024)
10.1.3 Latin America Antibody Sales Forecast by Country (2025-2030)
10.2 Latin America Antibody Market Size by Country
10.2.1 Latin America Antibody Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Antibody Market Size by Country (2019-2024)
10.2.3 Latin America Antibody Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Antibody Sales by Country
11.1.1 Middle East and Africa Antibody Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Antibody Sales by Country (2019-2024)
11.1.3 Middle East and Africa Antibody Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Antibody Market Size by Country
11.2.1 Middle East and Africa Antibody Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Antibody Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Antibody Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Antibody Value Chain Analysis
12.1.1 Antibody Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Antibody Production Mode & Process
12.2 Antibody Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Antibody Distributors
12.2.3 Antibody Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings